Because the average analyst target sits only about 2% above the latest price, it does not represent a meaningful "reach" scenario, so the $130 figure used here is a fallback objective grounded in public discussion rather than an analyst consensus. For context, S&P Global data shows 14 analysts with an average price target near $118.43 and a range of about $102.44 to $126.43, while TipRanks reports a roughly $117 average across its coverage. The consensus rating is a Hold, with a cluster of Buy and Hold ratings and a single Sell. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The dispersion is telling. Most firms cluster targets between roughly $108 and $123, but CFRA's published $141 target — based on a multiple of about 17 times its fiscal 2027 EPS estimate — sits far above the pack. Barclays and Desjardins maintain targets near $119, while TD Cowen raised its target to $123 in late August 2026. The wide gap between the $126 consensus high and CFRA's $141 reflects genuine disagreement over how much premium CIBC deserves after its re-rating.
At a latest price of about $116.04, moving to $130 would require a gain of roughly 12%, a modest-to-substantial move for a large-cap bank. The stock trades near the top of its 52-week range, which spans from about $79.65 to a high of $124.86, meaning $130 would require a decisive breakout to a new all-time-high territory above the prior peak.
The path would likely depend on continued earnings momentum. CIBC's fiscal 2026 third quarter, reported in late August 2026, showed adjusted EPS up roughly 26% year over year, revenue up about 15%, a roughly 200-basis-point improvement in the efficiency ratio, and a strong Common Equity Tier 1 (CET1) capital ratio of 13.4%. Estimates point to high-single-digit EPS growth into fiscal 2027, which would need to be sustained to justify further upside.
Several verified factors favor the shares. Earnings have consistently beaten expectations, with improving net interest margins and fee income cited by analysts as drivers. The bank is also reshaping its portfolio — selling its majority stake in CIBC Caribbean and expanding U.S. wealth management through Ann Partners — moves CFRA and others view as improving the business mix. A rising dividend (CA$1.07 per quarter) and a yield near 3% support investor demand, while a forward P/E (price-to-earnings) ratio below the broader market keeps the valuation defensible if earnings grow.
The principal risks are macro and valuation-related. As a Canadian bank, CIBC is sensitive to interest rates and the domestic housing market; a turn in credit conditions or rising provisions for credit losses would pressure earnings. The stock has already re-rated significantly, and its price sits close to analyst targets, limiting room for further multiple expansion. A Bank of Canada easing cycle that compresses net interest margins, or weaker capital-markets revenue, could also weigh on sentiment and keep the shares below $130.
The shares are near the top of a strong uptrend, with the 52-week high near $124.86 acting as immediate resistance. A sustained move above that level would be the first signal of a push toward the psychological $130 zone. On the downside, the prior consolidation area near $108–$110, where several analysts place targets, represents a key support level that would need to hold for the bullish structure to remain intact.
Analyst targets generally reflect a roughly 12-month research horizon, though individual firms differ, and the fallback $130 objective carries no fixed timeline. Investors should watch the next earnings release (expected in early December 2026) and guidance, any analyst target revisions, net interest margin trends, credit-loss provisions, and Canadian economic and rate data. Dividend announcements and progress on the U.S. wealth-management expansion are also relevant.
In my own research process, I find Tickeron’s AI Daily Buy/Sell Signals particularly helpful for monitoring names like CM that sit near range highs. The platform uses artificial intelligence to scan thousands of stocks and generate signals based on technical and market shifts, which can complement traditional analysis when evaluating potential moves toward levels like $130.
Can CM reach $130? The figure is a publicly discussed objective rather than a consensus forecast, and it sits roughly 12% above the latest price and just beyond the stock's 52-week high. The average analyst target of about $118 implies far less upside, while CFRA's $141 outlier shows the wide dispersion of opinion. Strong earnings growth, improving margins, a resilient capital position, and a rising dividend support the bull case, but a stretched valuation, interest-rate sensitivity, and credit risk are meaningful obstacles. The next earnings report and any revisions to analyst price targets will be the clearest near-term signals of whether the shares can make a durable push toward $130.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Stochastic Oscillator for CM moved into oversold territory on November 12, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
CM moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CM crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +2.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where CM advanced for three days, in 206 of 367 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 165 of 334 cases where CM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.
The 10-day RSI Indicator for CM moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 20 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 54%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CM as a result. In 39 of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.
The Moving Average Convergence Divergence Histogram (MACD) for CM turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 23 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 52%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
CM broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 4 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 21, placing this stock worse than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. CM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.768) is normal, around the industry mean (1.500). P/E Ratio (10.980) is within average values for comparable stocks, (11.703). Projected Growth (PEG Ratio) (1.713) is also within normal values, averaging (2.139). Dividend Yield (0.026) settles around the average of (0.035) among similar stocks. P/S Ratio (4.527) is also within normal values, averaging (3.867).
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks